Agrawal, A, Budney, AJ, Lynskey, MT (2012). The co-occurring use and misuse of cannabis and tobacco: a review. Addiction 107, 1221–1233.
Andreasson, S, Allebeck, P, Engstrom, A, Rydberg, U (1987). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 2, 1483–1486.
Arseneault, L, Cannon, M, Poulton, R, Murray, R, Caspi, A, Moffitt, TE (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal 325, 1212–1213.
Balter, KA, Balter, O, Fondell, E, Lagerros, YT (2005). Web-based and mailed questionnaires: a comparison of response rates and compliance. Epidemiology 16, 577–579.
Barr, RS, Culhane, MA, Jubelt, LE, Mufti, RS, Dyer, MA, Weiss, AP, Deckersbach, T, Kelly, JF, Freudenreich, O, Goff, DC, Evins, AE (2008). The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology 33, 480–490.
Bossong, MG, Niesink, RJ (2010). Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Progress in Neurobiology 92, 370–385.
Brody, AL, Olmstead, RE, London, ED, Farahi, J, Meyer, JH, Grossman, P, Lee, GS, Huang, J, Hahn, EL, Mandelkern, MA (2004). Smoking-induced ventral striatum dopamine release. American Journal of Psychiatry 161, 1211–1218.
Caspi, A, Moffitt, TE, Cannon, M, McClay, J, Murray, R, Harrington, H, Taylor, A, Arseneault, L, Williams, B, Braithwaite, A, Poulton, R, Craig, IW (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological Psychiatry 57, 1117–1127.
Compton, MT, Kelley, ME, Ramsay, CE, Pringle, M, Goulding, SM, Esterberg, ML, Stewart, T, Walker, EF (2009). Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. American Journal of Psychiatry 166, 1251–1257.
Costas, J, Sanjuan, J, Ramos-Rios, R, Paz, E, Agra, S, Tolosa, A, Paramo, M, Brenlla, J, Arrojo, M (2011). Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. Schizophrenia Research 127, 22–27.
Cougnard, A, Marcelis, M, Myin-Germeys, I, de Graaf, R, Vollebergh, W, Krabbendam, L, Lieb, R, Wittchen, HU, Henquet, C, Spauwen, J, van Os, J (2007). Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness–persistence model. Psychological Medicine 37, 513–527.
Dalack, GW, Healy, DJ, Meador-Woodruff, JH (1998). Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. American Journal of Psychiatry 155, 1490–1501.
Dalack, GW, Meador-Woodruff, JH (1996). Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature. Schizophrenia Research 22, 133–141.
Dean, B, Bymaster, FP, Scarr, E (2003). Muscarinic receptors in schizophrenia. Current Molecular Medicine 3, 419–426.
de Beer, H, van de Glind, G (2009). . CBO/Trimbos Instituut: Utrecht.
Degenhardt, L, Hall, W (2001). The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-Being. Nicotine and Tobacco Research 3, 225–234.
Ekman, A, Dickman, PW, Klint, A, Weiderpass, E, Litton, JE (2006). Feasibility of using web-based questionnaires in large population-based epidemiological studies. European Journal of Epidemiology 21, 103–111.
Fergusson, DM, Horwood, LJ, Swain-Campbell, NR (2003). Cannabis dependence and psychotic symptoms in young people. Psychological Medicine 33, 15–21.
Fusar-Poli, P, Borgwardt, S, Bechdolf, A, Addington, J, Riecher-Rossler, A, Schultze-Lutter, F, Keshavan, M, Wood, S, Ruhrmann, S, Seidman, LJ, Valmaggia, L, Cannon, T, Velthorst, E, de Haan, L, Cornblatt, B, Bonoldi, I, Birchwood, M, McGlashan, T, Carpenter, W, McGorry, P, Klosterkotter, J, McGuire, P, Yung, A (2012). The psychosis high-risk state: a comprehensive state-of-the-art review. Archives of General Psychiatry 19, 1–14.
Gosling, SD, Vazire, S, Srivastava, S, John, OP (2004). Should we trust web-based studies? A comparative analysis of six preconceptions about internet questionnaires. American Psychologist 59, 93–104.
Hanssen, M, Bak, M, Bijl, R, Vollebergh, W, van Os, J (2005). The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology 44, 181–191.
Henquet, C, Murray, R, Linszen, D, van Os, J (2005). The environment and schizophrenia: the role of cannabis use. Schizophrenia Bulletin 31, 608–612.
Henquet, C, Rosa, A, Krabbendam, L, Papiol, S, Fananas, L, Drukker, M, Ramaekers, JG, van Os, J (2006). An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 31, 2748–2757.
Johns, LC, van Os, J (2001). The continuity of psychotic experiences in the general population. Clinical Psychology Review 21, 1125–1141.
Jubelt, LE, Barr, RS, Goff, DC, Logvinenko, T, Weiss, AP, Evins, AE (2008). Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia. Psychopharmacology (Berlin) 199, 89–98.
Kahn, RS, Linszen, DH, van Os, J, Wiersma, D, Bruggeman, R, Cahn, W, de Haan, L, Krabbendam, L, Myin-Germeys, I; Genetic Risk and Outcome in Psychosis (GROUP) Investigators (2011). Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs. Archives of General Psychiatry 68, 138–147.
Karatekin, C, White, T, Bingham, C (2010). Shared and nonshared symptoms in youth-onset psychosis and ADHD. Journal of Attention Disorders 14, 121–131.
Kelly, C, McCreadie, RG (1999). Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. American Journal of Psychiatry 156, 1751–1757.
Konings, M, Bak, M, Hanssen, M, van Os, J, Krabbendam, L (2006). Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatrica Scandinavica 114, 55–61.
Krabbendam, L, Myin-Germeys, I, Bak, M, van Os, J (2005). Explaining transitions over the hypothesized psychosis continuum. Australian and New Zealand Journal of Psychiatry 39, 180–186.
Krishnadas, R, Jauhar, S, Telfer, S, Shivashankar, S, McCreadie, RG (2012). Nicotine dependence and illness severity in schizophrenia. British Journal of Psychiatry.
Large, M, Sharma, S, Compton, MT, Slade, T, Nielssen, O (2011). Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Archives of General Psychiatry 68, 555–561.
Lasser, K, Boyd, JW, Woolhandler, S, Himmelstein, DU, McCormick, D, Bor, DH (2000). Smoking and mental illness: a population-based prevalence study. Journal of the American Medical Association 284, 2606–2610.
Ledgerwood, DM, Goldberger, BA, Risk, NK, Lewis, CE, Price, RK (2008). Comparison between self-report and hair analysis of illicit drug use in a community sample of middle-aged men. Addictive Behaviors 33, 1131–1139.
Lee, SS, Humphreys, KL, Flory, K, Liu, R, Glass, K (2011). Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clinical Psychology Review 31, 328–341.
Lynskey, MT, Fergusson, DM, Horwood, LJ (1998). The origins of the correlations between tobacco, alcohol, and cannabis use during adolescence. Journal of Child Psychology and Psychiatry 39, 995–1005.
Lyon, ER (1999). A review of the effects of nicotine on schizophrenia and antipsychotic medications. Psychiatric Services 50, 1346–1350.
Macleod, J, Davey, SG, Hickman, M, Egger, M (2007). Cannabis and psychosis. Lancet 370, 1539–1540.
Macleod, J, Hickman, M (2006). Commentary: understanding pathways to cannabis use and from use to harm. International Journal of Epidemiology 35, 680–682.
Macleod, J, Oakes, R, Copello, A, Crome, I, Egger, M, Hickman, M, Oppenkowski, T, Stokes-Lampard, H, Davey, SG (2004). Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 363, 1579–1588.
Malcolm, CP, Picchioni, MM, DiForti, M, Sugranyes, G, Cooke, E, Joseph, C, McQueen, G, Paparelli, A, Stilo, S, O'Connor, J, Morgan, C, Murray, RM, Hodgins, S (2011). Pre-morbid conduct disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis. Schizophrenia Research 126, 81–86.
Mattejat, F, Remschmidt, H (2008). The children of mentally ill parents. Deutsches Ärzteblatt International 105, 413–418.
McGrath, J, Welham, J, Scott, J, Varghese, D, Degenhardt, L, Hayatbakhsh, MR, Alati, R, Williams, GM, Bor, W, Najman, JM (2010). Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Archives of General Psychiatry 67, 440–447.
Meyerson, P, Tryon, WW (2003). Validating internet research: a test of the psychometric equivalence of internet and in-person samples. Behavior Research Methods, Instruments and Computers 35, 614–620.
Mobascher, A, Winterer, G (2008). Mechanisms of nicotine dependence [in German]. Pneumologie 62, 553–561.
Monshouwer, K, van Dorsselaer, S, Verdurmen, J, Bogt, TT, de Graaf, R, Vollebergh, W (2006). Cannabis use and mental health in secondary school children. Findings from a Dutch survey. British Journal of Psychiatry 188, 148–153.
Moore, TH, Zammit, S, Lingford-Hughes, A, Barnes, TR, Jones, PB, Burke, M, Lewis, G (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319–328.
Mortensen, PB, Pedersen, CB, Westergaard, T, Wohlfahrt, J, Ewald, H, Mors, O, Andersen, PK, Melbye, M (1999). Effects of family history and place and season of birth on the risk of schizophrenia. New England Journal of Medicine 340, 603–608.
Mullin, K, Gupta, P, Compton, MT, Nielssen, O, Harris, A, Large, M (2012). Does giving up substance use work for patients with psychosis? A systematic meta-analysis. Australian and New Zealand Journal of Psychiatry 46, 826–839.
Murray, RM, Morrison, PD, Henquet, C, Di Forti, M (2007). Cannabis, the mind and society: the hash realities. Nature Reviews Neuroscience 8, 885–895.
Myles, N, Newall, H, Nielssen, O, Large, M (2012). The association between cannabis use and earlier age at onset of schizophrenia and other psychoses: meta-analysis of possible confounding factors. Current Pharmaceutical Design 18, 5055–5069.
Obermeier, M, Mayr, A, Schennach-Wolff, R, Seemuller, F, Moller, HJ, Riedel, M (2010). Should the PANSS be rescaled? Schizophrenia Bulletin 36, 455–460.
Punnoose, S, Belgamwar, MR (2006). Nicotine for schizophrenia. Cochrane Database of Systematic Reviews Issue 25, Art. No. CD004838.
Ripoll, N, Bronnec, M, Bourin, M (2004). Nicotinic receptors and schizophrenia. Current Medical Research and Opinion 20, 1057–1074.
Rossler, W, Hengartner, MP, Angst, J, Ajdacic-Gross, V (2012). Linking substance use with symptoms of subclinical psychosis in a community cohort over 30 years. Addiction 107, 1174–1184.
Ruhrmann, S, Schultze-Lutter, F, Salokangas, RK, Heinimaa, M, Linszen, D, Dingemans, P, Birchwood, M, Patterson, P, Juckel, G, Heinz, A, Morrison, A, Lewis, S, von Reventlow, HG, Klosterkotter, J (2010). Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Archives of General Psychiatry 67, 241–251.
Saha, S, Scott, JG, Varghese, D, Degenhardt, L, Slade, T, McGrath, JJ (2011). The association between delusional-like experiences, and tobacco, alcohol or cannabis use: a nationwide population-based survey. BMC Psychiatry 11, 202.
Schubart, CD, van Gastel, WA, Breetvelt, EJ, Beetz, SL, Ophoff, RA, Sommer, IE, Kahn, RS, Boks, MP (2011). Cannabis use at a young age is associated with psychotic experiences. Psychological Medicine 41, 1301–1310.
Sørensen, HJ, Mortensen, EL, Reinisch, JM, Mednick, SA (2011). A prospective study of smoking in young women and risk of later psychiatric hospitalization. Nordic Journal of Psychiatry 65, 3–8.
Stefanis, NC, Hanssen, M, Smirnis, NK, Avramopoulos, DA, Evdokimidis, IK, Stefanis, CN, Verdoux, H, van Os, J (2002). Evidence that three dimensions of psychosis have a distribution in the general population. Psychological Medicine 32, 347–358.
van Gastel, WA, Tempelaar, W, Bun, C, Schubart, CD, Kahn, RS, Plevier, C, Boks, MP (2012 a). Cannabis use as an indicator of risk for mental health problems in adolescents: a population-based study at secondary schools. Psychological Medicine. Published online: 3 December 2012. doi:10.1017/S0033291712002723.
van Gastel, WA, Wigman, JT, Monshouwer, K, Kahn, RS, van Os, J, Boks, MP, Vollebergh, WA (2012 b). Cannabis use and subclinical positive psychotic experiences in early adolescence: findings from a Dutch survey. Addiction 107, 381–387.
van Os, J, Bak, M, Hanssen, M, Bijl, RV, de Graaf, R, Verdoux, H (2002). Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 156, 319–327.
Vreeker, A, Schubart, CD, van Gastel, WA, Kahn, RS, Boks, MP (2013). Advanced paternal age and vulnerability to psychotic-like experiences in the offspring. Schizophrenia Research 143, 74–76.
Weiser, M, Reichenberg, A, Grotto, I, Yasvitzky, R, Rabinowitz, J, Lubin, G, Nahon, D, Knobler, HY, Davidson, M (2004). Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study. American Journal of Psychiatry 161, 1219–1223.
Wignall, ND, de Wit, H (2011). Effects of nicotine on attention and inhibitory control in healthy nonsmokers. Experimental and Clinical Psychopharmacology 19, 183–191.
Wiles, NJ, Zammit, S, Bebbington, P, Singleton, N, Meltzer, H, Lewis, G (2006). Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. British Journal of Psychiatry 188, 519–526.
Yung, AR, Phillips, LJ, Yuen, HP, Francey, SM, McFarlane, CA, Hallgren, M, McGorry, PD (2003). Psychosis prediction: 12-month follow up of a high-risk (‘prodromal’) group. Schizophrenia Research 60, 21–32.
Zaldivar, BF, Garcia Montes, JM, Flores, CP, Sanchez, SF, Lopez, RF, Molina, MA (2009). Validity of the self-report on drug use by university students: correspondence between self-reported use and use detected in urine. Psicothema. 21, 213–219.
Ziedonis, D, Hitsman, B, Beckham, JC, Zvolensky, M, Adler, LE, udrain-McGovern, J, Breslau, N, Brown, RA, George, TP, Williams, J, Calhoun, PS, Riley, WT (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine and Tobacco Research 10, 1691–1715.